A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of DFUs and VLUs.
This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.
100 项与 Stability Biologics LLC 相关的临床结果
0 项与 Stability Biologics LLC 相关的专利(医药)
100 项与 Stability Biologics LLC 相关的药物交易
100 项与 Stability Biologics LLC 相关的转化医学